Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
29.96
-1.48 (-4.71%)
At close: Nov 20, 2026, 4:00 PM EST
30.20
+0.24 (0.80%)
After-hours: Nov 20, 2026, 5:33 PM EST
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $3.4 billion as of November 20, 2026. It is the 4,488th most valuable company in the world and the 1,380th biggest in the United States. Its market cap has increased by 24.29% in one year.
Market Cap
3.40B
Enterprise Value
2.69B
1-Year Change
24.29%
Global Rank
Country Rank
#1,380 United States
Category
ChartMarket Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $3.40B, an increase of 9,704.64%. That is a compound annual growth rate of 44.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.40B | 14.54% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 3.82B |
| Xenon Pharmaceuticals | 3.70B |
| Relay Therapeutics | 3.60B |
| AbCellera Biologics | 3.59B |
| Disc Medicine | 3.52B |
| Iovance Biotherapeutics | 3.50B |
| Arcutis Biotherapeutics | 3.49B |
| Parabilis Medicines | 3.46B |